Sign in
CompletedNo phase

Evaluation of a Multilevel Intervention on Adult COVID-19 and Influenza Vaccination Rate

Key facts

Who runs it
Mayo Clinic
Where
Rochester, United StatesSee the site
Trial code
Status
Completed
People taking part
114,165 people enrolled
Started
21 Oct 2024
Ended
30 Apr 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Patient letter and clinician communication
Record updated
5 August 2025

Who can take part

Age
19 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Patients 19 years and older
  • Patients empaneled to 1 of 8 adult primary care practices as of September 2024

Who cannot take part

  • Patients 18 years or younger
  • Patients not empaneled to 1 of 8 adult primary care practices as of September 2024

Where in United States

  • Mayo ClinicRochester, United States

About the trial

What the trial wants to find out

The study will test two tactics to improve uptake of two vaccines in adults. The vaccines prevent COVID-19 and influenza. Both are common and harmful. Most adults do not get either vaccine. This is despite strong recommendations that all adults get both vaccines.

Read full original descriptionShow less

The study will involve adult patients at eight Mayo Clinic primary care practices in Rochester and Kasson. The study will test the two tactics together. Four clinics will get the two tactics. The other four clinics will not. The study will randomly assign the two tactics to the clinics. One tactic is to send a letter by US mail to the patient. The letter will state strong recommendations on getting both vaccines now. It will tell patients how to get the vaccines now. The second tactic is to send monthly emails to clinicians. It will remind them to use every visit to vaccinate patients against COVID-19 and influenza. The study will compare the uptake of the two vaccines after six months in the clinics with and without the two tactics.

The 2 groups in the trial

  • Patient letter and clinician communicationTreatment being tested

    Each patient will be mailed a letter and each patient's clinician will receive a monthly email communicating information about making a strong recommendation for influenza and COVID-19 vaccination

  • No interventionNo study treatment, for comparison

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
5 August 2025